Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL388512 | 0.87 | TSHR (0.36) | TSHR | |
| SCHEMBL390270 | 0.82 | TSHR (0.31) | TSHR | |
| SCHEMBL384518 | 0.81 | — | — | |
| SCHEMBL388974 | 0.81 | — | — | |
| SCHEMBL384517 | 0.81 | — | — | |
| SCHEMBL459676 | 0.77 | — | — | |
| SCHEMBL459675 | 0.77 | — | — | |
| SCHEMBL15303052 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL3338598 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL385400 | 0.76 | TSHR (0.33) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101697-B2 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2012-01-24 | — | — | US | claimed |
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2006-08-03 | — | — | US | claimed |
| EP-1883658-B2 | METHOD FOR PREPARING LOW MOLECULAR WEIGHT POLYMERS | BRIDGESTONE CORP (JP) | 2016-01-27 | — | — | EP | disclosed |
| US-8101697-B2 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8058351-B2 | Method for preparing low molecular weight polymers | BRIDGESTONE CORPORATION (JP) | 2011-11-15 | — | — | US | disclosed |
| EP-1883658-B1 | METHOD FOR PREPARING LOW MOLECULAR WEIGHT POLYMERS | BRIDGESTONE CORP (JP) | 2011-08-03 | — | — | EP | disclosed |
| US-20090105423-A1 | Method for preparing low molecular weight polymers | BRIDGESTONE CORPORATION (JP) | 2009-04-23 | — | — | US | disclosed |
| EP-1883658-A1 | METHOD FOR PREPARING LOW MOLECULAR WEIGHT POLYMERS | Bridgestone Corporation (JP) | 2008-02-06 | — | — | EP | disclosed |
| WO-2006127483-A1 | METHOD FOR PREPARING LOW MOLECULAR WEIGHT POLYMERS | BRIDGESTONE CORPORATION (JP) | 2006-11-30 | — | — | WO | disclosed |
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | BRIDGESTONE CORPORATION (JP) | 2006-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060173145-A1 | Multi-functionalized high-trans elastomeric polymers | VCL, PUF60, JMJD6 | TSHR 4359/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.